Generated October 2026 · Clinical Deep Dive 0 Comments At the American College of Cardiology’s 2026 Scientific Sessions, a trial called SPIRIT-HF delivered a genuinely unsettling result for one of cardiology’s oldest and cheapest drugs. Spironolactone, tested against placebo in patients with heart failure with preserved or mildly reduced ejection fraction…
Read More
